Authors
Loading...
Retrospective analysis shows that tumor markers and immunoinflammatory indicators predict 2-year mortality in NSCLC patients, suggesting tailored treatment strategies.
Zhou et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: